2,523
Views
1
CrossRef citations to date
0
Altmetric
Original Research Article

Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study

, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2065755 | Received 07 Feb 2022, Accepted 09 Apr 2022, Published online: 19 Apr 2022

References

  • Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–9.
  • Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1.
  • Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–1153.
  • Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol. 2013;28(4):64–70. Suppl.
  • Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69(3):564–568.
  • Greenland Statistics Available online: https://stat.gl/default.asp?lang=en (accessed on 2021 Apr 8).
  • Scott JD, Garland N. Chronic liver disease in aboriginal North Americans. World J Gastroenterol. 2008;14(29):4607–4615.
  • Andersen S, Rex KF, Noahsen P, et al. Forty-five year trends in overweight and obesity in an indigenous Arctic Inuit Society in transition and spatiotemporal trends. Am J Hum Biol Off J Hum Biol Counc. 2014;26:511–517.
  • Jørgensen ME, Bjeregaard P, Borch-Johnsen K. Diabetes and impaired glucose tolerance among the Inuit population of Greenland. Diabetes Care. 2002;25(10):1766–1771.
  • Pedersen ML. High awareness of diabetes in the health care system in Greenland measured as a proportion of population tested with glycated haemoglobin within 2 years. Diabetol Metab Syndr. 2017;9(1):30.
  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642.
  • Pedersen ML. Microvascular complications in Nuuk, Greenland, among Greenlanders and non-Greenlanders diagnosed with type 2 diabetes. Diabet Res Clin Pract. 2018;136:1–6.
  • Okkes IM, Becker HW, Bernstein RM, et al. The March 2002 update of the electronic version of ICPC-2. A step forward to the use of ICD-10 as a nomenclature and a terminology for ICPC-2. Fam Pract. 2002;19(5):543–546.
  • Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
  • Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7:1104–1112.
  • Lin Z-H, Xin Y-N, Dong Q-J, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726–736.
  • Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Ann Int Med. 2013;159(5):372.
  • Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–237.
  • Andersen S, Fleischer Rex K, Noahsen P, et al. Raised BMI cut-off for overweight in Greenland Inuit – a review. Int J Circumpolar Health. 2013:72.
  • Jørgensen ME, Borch-Johnsen K, Stolk R, et al. Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care. 2013;36(10):2988–2994.
  • Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev an off J Int Assoc Study Obes. 2010;11(1):11–18.
  • Bjerregaard P, Jørgensen ME, Borch-Johnsen K. Serum lipids of Greenland Inuit in relation to Inuit genetic heritage, westernisation and migration. Atherosclerosis. 2004;174(2):391–398.
  • Noahsen P, Andersen S. Ethnicity influences BMI as evaluated from reported serum lipid values in Inuit and non-Inuit: raised upper limit of BMI in Inuit? Ethn Dis. 2013;23(1):77–82.
  • Rudkowska I, Dewailly E, Hegele RA, et al. Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr. 2013;109(5):953–961.
  • de Knijff P, Johansen LG, Rosseneu M, et al. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb a J Vasc Biol. 1992;12(12):1371–1379.
  • Larsen TLJ, Jørgensen ME, Pedersen ML, et al. Low prevalence of retinopathy among Greenland Inuit. Int J Circumpolar Health. 2021;80(1):1938420.
  • Rokkjaer MS, Jensen MT, Grønbaek H, et al. Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital. Int J Circumpolar Health. 2006;65(2):162–168.
  • Pedersen ML, Jacobsen JL, Lynge AR. Micro- and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland. Int J Circumpolar Health. 2010;69(2):195–207.
  • McGarrah RW. Metabolic anthropology: selection pressure shapes fatty acid metabolism in Greenlandic Inuit populations. Circ Cardiovasc Genet. 2017;10(3)).
  • Moltke I, Grarup N, Jørgensen ME, et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature. 2014;512(7513):190–193.
  • Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122(6):1649–1657.
  • Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22(6):437–443.
  • Nomura K, Yano E, Shinozaki T, et al. Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups. J Occup Health. 2004;46(6):423–428.
  • Gantzel RH, Kjær MB, Laursen TL, et al. Macrophage activation markers, soluble CD163 and Mannose receptor, in liver fibrosis. Front Med. 2020;7:615599.
  • Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.
  • Wong RJ, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2017;46(10):974–980.
  • García-Compeán D, Villarreal-Pérez JZ, Cavazos MEDLO, et al. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Ann Hepatol. 2020;19(3):258–264.
  • Poynard T, Lebray P, Ingiliz P, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol. 2010;10(1):40.
  • Fischer GE, Bialek SP, Homan CE, et al. Chronic liver disease among Alaska-Native people, 2003-2004. Am J Gastroenterol. 2009;104(2):363–370.
  • Spradling PR, Bulkow L, Teshale EH, et al. Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection. J Hepatol. 2014;61(4):785–791.
  • Pedersen ML. Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken. Int J Circumpolar Health. 2019;78(sup1):1709257.
  • Gupta A, Anoop S, Ansari IA, et al. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. Clin Nutr ESPEN. 2021;46:519–526.
  • Bjerregaard P, Larsen CVL, Sørensen IK, et al. Alcohol in Greenland 1950-2018: consumption, drinking patterns, and consequences. Int J Circumpolar Health. 2020;79(1):1814550.
  • Lavik B, Holmegaard C, Becker U. Drinking patterns and biochemical signs of alcoholic liver disease in Danish and Greenlandic patients with alcohol addiction. Int J Circumpolar Health. 2006;65(3):219–227.
  • Rex KF, Andersen S, Krarup HB. Hepatitis B among Inuit: a review with focus on Greenland Inuit. World J Hepatol. 2015;7(9):1265–1271.
  • Rex KF, Krarup HB, Laurberg P, et al. Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland. Scand J Gastroenterol. 2012;47(6):692–701.
  • Ko HH, Chung HV, McMahon BJ, et al. Liver disease in the indigenous populations of the Arctic, sub-Arctic, and Pacific Northwest: an approach to investigations in Alaska and British Columbia. B C Med J. 2006;48:216–221.